Skip to main content

2024 ISPE Annual Meeting Main banner

Browse by Poster Title

Browse by Poster Title

30 results found

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

F
170
FACTOR XA INHIBITOR–RELATED MAJOR BLEEDING EVENTS IN THE NETHERLANDS

Favorite
CSPOT07
Factors Associated with Adherence to Long-Acting Injectable Antipsychotics Among Medicare Beneficiaries

Favorite
115
Factors associated with potentially inappropriate medicines use in older adults during the covid-19 pandemic in two Brazilian municipalities: a cross-sectional study

Favorite
171
Factors Associated with Reinitiation and Subsequent Discontinuation of Antiplatelet Medication in Patients with Peripheral Arterial Disease

Favorite
182
Factors associated with Remote Recruiting in Patient Centered Outcomes Research Studies

Favorite
ASPOT43
Fall risk increasing adverse reactions (FRIARs) and fracture risk: A nested case control study

Favorite
333
Fatal intoxications with paracetamol in Sweden – a majority of fatalities had a prescription

Favorite
310
Fatal intoxications with zopiclone and alprazolam in Sweden during 2012-2020 – a register-based study

Favorite
016
FDA REMS: Characterizing Burdens and Case Application of a Novel Integrated Ethical Framework

Favorite
202
Fear of Missing Out: Drug Availability in Canada versus the USA

Favorite
172
Feasibility Assessment of Hypertension among Patients with Diabetic Macular Edema using Real World Data

Favorite
116
Feasibility of a Federated Network Analysis Using Real-World Data Mapped to OMOP Common Data Model to Estimate Healthcare Resource Utilisation and Costs of Imminent Subsequent Fracture

Favorite
183
Feasibility of Constructing an External Control Arm with Real-World Data to Augment Subgroups in Cardiorenal Trials: A Matched Cohort Study Focusing on Trial Subgroups of Sodium-Glucose Cotransport 2 Inhibitor Users at Baseline

Favorite
360
Feasibility of Prospective Real-World Studies to Fulfill Regulatory Commitments and Requirements in Oncology within the United States (US)

Favorite
184
Feasibility of the OMOP Common Data Model for German claims data

Favorite
017
Feasibility of Using Deidentified Positron Emission Tomography–Computed Tomography (PET-CT) Scans to Support a Blinded Independent Central Review for Lymphoma Treatment Response Assessment using Real-World Data

Favorite
185
Federated learning as a smart tool for data analysis in infectious disease research: a scoping review

Favorite
264
Fetal and Neonatal Alloimmune Thrombocytopenia: Systematic Literature Review and Challenges Encountered

Favorite
342
Final Results from Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine

Favorite
265
Finding the Forest in the TreeScan: A Big Data Driven Approach to Screening Drug Use in Pregnancy

Favorite
266
First trimester tetracycline use and risk of major congenital malformations: A cohort study

Favorite
058
First-line therapy discontinuation among Brazilian multiple myeloma patients: incidence and reasons

Favorite
154
Fit-for-purpose evaluation of Real-World Data for vaccines and medicines safety studies: the INSIGHT tool

Favorite
186
Flexible parametric survival models for simultaneous estimation on multiple timescales: an application using nationwide Swedish register data

Favorite
059
Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study

Favorite
260
Fluoroquinolones and the risk of aortic aneurysm or dissection: a cohort study in German health claims data

Favorite
017
Forging a Path for Transporting Real-World Evidence: Existing Applications & Proposed Practices

Favorite
261
Framework for Public-Private Partnerships for Real-World Data Exchange of Immunizations Records for Public Health Surveillance

Favorite
262
Frequency and Duration of Antibiotic Shortages: A Global Comparison

Favorite
267
Frequency of diagnosis codes for infant outcomes appearing on maternal health insurance claims

Favorite